A Postpartum Model in Rat: Behavioral and Gene Expression Changes Induced by Ovarian Steroid Deprivation

Biological Psychiatry

Volumn 64, Issue 4, 2008, Pages 311-319

  Suda, Shiro ^a   Segi Nishida, Eri ^a   Newton, Samuel S ^a   Duman, Ronald S ^a  

^a Yale University School of Medicine   (United States)

Author keywords

Aggression; anxiety; behavior; depression; gene profiling; postpartum depression

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AQUAPORIN 4; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SEROTONIN TRANSPORTER; SMAD4 PROTEIN; STEROID;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; FEMALE; GENE CONTROL; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; AQUAPORIN 4; BEHAVIOR, ANIMAL; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DEPRESSION, POSTPARTUM; DISEASE MODELS, ANIMAL; ESTRADIOL; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; HELPLESSNESS, LEARNED; MAZE LEARNING; MYOGENIC REGULATORY FACTORS; NERVE TISSUE PROTEINS; OVARIECTOMY; POSTPARTUM PERIOD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; STEROIDS; SWIMMING;

EID: 48149111514     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.03.029     Document Type: Article

References (74)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision (2000), American Psychiatric Association, Washington, DC
2. Miller L.J. Postpartum depression. JAMA 287 (2002) 762-765
3. Bloch M., Daly R.C., and Rubinow D.R. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 44 (2003) 234-246
4. Reck C., Hunt A., Fuchs T., Weiss R., Noon A., Moehler E., et al. Interactive regulation of affect in postpartum depressed mothers and their infants: An overview. Psychopathology 37 (2004) 272-280
5. Brockington I. Postpartum psychiatric disorders. Lancet 363 (2004) 303-310
6. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., and Rubinow D.R. Effect of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157 (2000) 924-930
7. Molina-Hernandez M., and Tellez-Alcantara N.P. Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim. Psychoneuroendocrinology 26 (2001) 479-491
8. Galea L.A., Wide J.K., and Barr A.M. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 122 (2001) 1-9
9. Stoffel E.C., and Craft R.M. Ovarian hormone withdrawal-induced "depression" in female rats. Physiol Behav 83 (2004) 505-513
10. Lye S.J., Nicholson B.J., Mascarenhas M., MacKenzie L., and Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology 132 (1993) 2380-2386
11. 1A receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 74 (2001) 135-142
12. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
13. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121 (1995) 66-72
14. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
15. Lacroix L., Broersen L.M., Weiner I., and Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 84 (1998) 431-442
16. File S.E., Lippa A.S., Beer B., and Lippa M.T. Animal tests of anxiety. Current Protocols in Neuroscience (2004), John Wiley & Sons, Hoboken, New Jersey 8.3.1-8.3.22
17. Miczek K.A. A new test for aggression in rats without aversive stimulation: Differential effects of d-amphetamine and cocaine. Psychopharmacology (Berl) 60 (1979) 253-259
18. de Boer S.F., Lesourd M., Mocaer E., and Koolhaas J.M. Selective antiaggressive effect of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine 1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J Pharmacol Exp Ther 288 (1999) 1125-1133
19. Consiglio A.R., Borsoi A., Pereira G.A., and Lucion A.B. Effects of oxytocin microinjected into the central amygdaloid nucleus and bed nucleus of stria terminalis on maternal aggressive behavior in rats. Physiol Behav 85 (2005) 354-362
20. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., and Duman R.S. Gene profile of electroconvulsive seizures: Induction of neurotrophic and angiogenic factors. J Neurosci 23 (2003) 10841-10851
21. Warner-Schmidt J.L., and Duman R.S. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 16 (2006) 239-249
22. Chen A.C., Shirayama Y., Shin K.H., Neve R.L., and Duman R.S. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49 (2001) 753-762
23. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
24. Koss W.A., Gehlert D.R., and Shekhar A. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats. Horm Behav 46 (2004) 158-164
25. Ho Y.J., Wang C.F., Hsu W., Tseng T., Hsu C.C., Kao M.D., and Tsai Y.F. Psychoimmunological effects of doscorea in ovariectomized rats: Role of anxiety level. Ann Gen Psychiatry 6 (2007) 21-28
26. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29 (2004) 185-193
27. Newton S.S., and Duman R.S. Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res 1 (2004) 261-267
28. Karege F., Perroud N., Burkhardt S., Schwald M., Ballmann E., La Harpe R., and Malafosse A. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61 (2007) 240-245
29. Merendino R.A., Di Rosa A.E., Di Pasquale G., Minciullo P.L., Mangraviti C., Costantino A., et al. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm 11 (2002) 265-267
30. Porsolt R.D., Bertin A., Blavet N., Deniel M., and Jalfre M. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57 (1979) 201-210
31. Cannizzaro G., Flugy A., Cannizzaro C., Gagliano M., and Sabatino M. Effects of desipramine and alprazolam in the forced swim test in rats after long-lasting termination of chronic exposure to picrotoxin and pentylenetetrazol. Eur Neuropsychopharmacol 3 (1993) 477-484
32. Tezval H., Jahn O., Todorovic C., Sasse A., Eckart K., and Spiess J. Cortagine, a specific agonist of the corticotrophin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci U S A 101 (2004) 9468-9473
33. Nishimura H., Ida Y., Tsuda A., and Tanaka M. Opposite effects of diazepam and b-CCE on immobility and straw-climbing behavior of rats in a modified forced swim test. Pharmacol Biochem Beh 33 (1989) 227-231
34. Consoli D., Fedotova J., Micale V., Sapronov N.S., and Drago F. Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur J Pharmacol 520 (2005) 100-107
35. Hendrick V., Altshuler L., Strouse T., and Grosser S. Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment. Depress Anxiety 11 (2000) 66-72
36. Smith S.S., Gong Q.H., Li X., Moran M.H., Bitran D., Frye C.A., and Hsu F.C. Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J Neurosci 18 (1998) 5275-5284
37. Bitran D., Shiekh M., and McLeod M. Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 7 (1995) 171-177
38. Laconi M.R., Casteller G., Gargiulo P.A., Bregonzio C., and Cabrera R.J. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur J Pharmacol 417 (2001) 111-116
39. Amin Z., Mason G.F., Cavus I., Krystal J.H., Rothman D.L., and Epperson C.N. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav 84 (2006) 635-643
40. Erskine M.S., Barfield R.J., and Goldman B.D. Intraspecific fighting during late pregnancy and lactation in rats and effects of litter removal. Behav Biol 23 (1978) 206-218
41. Hansen S., and Ferreira A. Food intake, aggression, and fear behavior in the mother rat: Control by neural systems concerned with milk ejection and maternal behavior. Behav Neurosci 100 (1986) 64-70
42. Rosenblatt J.S., Factor E., and Mayer A.D. Relationship between maternal aggression and maternal care in the rat. Aggress Behav 20 (1994) 243-255
43. Ferreira A., Hansen S., Nielsen M., Archer T., and Minor B.G. Behavior of mother rats in conflict tests sensitive to anti-anxiety agents. Behav Neurosci 103 (1989) 193-201
44. Ferreira A., Pereira M., Agrati D., Uriarte N., and Fernandez-Guasti A. Role of maternal behavior on aggression, fear and anxiety. Physiol Behav 77 (2002) 197-204
45. 2+/calmodulin-dependent protein kinase II. Biochem J 364 (2002) 593-611
46. Tighilet B., Hashikawa T., and Jones E.G. Cell- and lamina-specific expression and activity-dependent regulation of type II calcium/calmodulin-dependent protein kinase isoforms in monkey visual cortex. J Neurosci 18 (1998) 2129-2146
47. Silva A.J., Paylor R., Wehner J.M., and Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257 (1992) 206-211
48. Bach M.E., Hawkins R.D., Osman M., Kandel E.R., and Mayford M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81 (1995) 905-915
49. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., and Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science 274 (1996) 1678-1683
50. Frankland P.W., O'Brien C., Ohno M., Kirkwood A., and Silva A.J. Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory. Nature 411 (2001) 309-313
51. Popoli M., Vocaturo C., Perez J., Smeraldi E., and Racagni G. Presynaptic Ca2+/calmodulin-dependent protein kinase II: Autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol Pharmacol 48 (1995) 623-629
52. Xing G., Russell S., Hough C., O'Grady J., Zhang L., Yang S., et al. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 13 (2002) 501-505
53. Amada N., Aihara K., Ravid R., and Horie M. Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease. Neuroreport 16 (2005) 1809-1813
54. Novak G., Seeman P., and Tallerico T. Increased expression of calcium/calmodulin-dependent protein kinase II beta in frontal cortex in schizophrenia and depression. Synapse 59 (2006) 61-68
55. Celano E., Tiraboschi E., Consogno E., D'Urso G., Mbakop M.P., Gennarelli M., et al. Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs. Biol Psychiatry 53 (2003) 442-449
56. Tiraboschi E., Giambelli R., D'Urso G., Galietta A., Barbon A., de Bartolomeis A., et al. Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. Neuroreport 15 (2004) 2393-2396
57. Blakely R.D., De Felice L.J., and Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196 (1994) 263-281
58. Frazer A. Antidepressants. J Clin Psychiatry 58 (1997) 9-25
59. Blakely R.D., Ramamoorthy S., Schroeter S., Qian Y., Apparsundaram S., Galli A., and DeFelice L.J. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44 (1998) 169-178
60. Ramamoorthy S., Samuvel D.J., Buck E.R., Rudnick G., and Jayanthi L.D. Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J Biol Chem 282 (2007) 11639-11647
61. Djalali S., Holtje M., Grosse G., Rothe T., Stroh T., Grosse J., et al. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 92 (2005) 616-627
62. Rubinow D.R., Schimidt P.J., and Roca C.A. Estrogen-serotonin interactions: Implications for affective regulation. Biol Psychiatry 44 (1998) 839-850
63. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., and Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22 (2002) 6766-6772
64. Mao Z., Bonni A., Xia F., Nadal-Vicens M., and Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286 (1999) 785-790
65. Kalcheim C., Barde Y.A., Thoenen H., and Le Douarin N.M. In vivo effect of brain-derived neurotrophic factor on the survival of developing dorsal root ganglion cells. EMBO J 10 (1987) 2871-2873
66. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006) 1116-1127
67. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 11 (1995) 7539-7547
68. Hoshaw B.A., Malberg J.E., and Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037 (2005) 204-208
69. Hevers W., and Luddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18 (1998) 35-86
70. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., and Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
71. Badaut J., Lasbennes F., Magistretti P.J., and Regli L. Aquaporins in brain: Distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 22 (2002) 367-378
72. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., and Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9 (2004) 406-416
73. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16 (1997) 5353-5362
74. Dow A.L., Russell D.S., and Duman R.S. Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: Effects in behavioral models. J Neurosci 25 (2005) 4908-4916